Video Center


The OBR Video Center Features educational videos covering a wide range of oncology specific topics.

Edward Li provides examples of oncology targeting biosimilars that are nearing approval

Edward Li, PharmD, MPH, BCOP, Associate Professor, University of New England College of Pharmacy, discusses oncology targeting biosimilars that are nearing approval

Tags: BiosimilarsCOA Conference CoverageFDA/Regulatory (includes NICE, EMA, CHMP, Biosimilars, Generics)

Published: 04 May 2017

Recent Videos

video

Che-Kai Tsao, MD, elaborates on results from the TITAN study in mCRPC from ASCO '19

Dr. Tsao, Associate Professor of Medicine, Icahn School of Medicine at Mt Sinai, Medical Director, Ruttenberg Treatment Center, Mt. Sinai ...

video

Sandip Patel, MD, on treatment in the 2nd line setting following PD-L1 targeting agents

Dr. Patel, Assistant Professor of Medicine, Deputy Director, San Diego Center for Precision Immunotherapy, Co-Leader, Experimental Therapeutics (Phase 1), UC ...

video

Sandip Patel, MD, speculates on the impact of the RELAY trial presented at ASCO 2019

Dr. Patel, Assistant Professor of Medicine, Deputy Director, San Diego Center for Precision Immunotherapy, Co-Leader, Experimental Therapeutics (Phase 1), UC ...

video

Che-Kai Tsao, MD, offers opinion on the results of the ENZAMET study in mHSPC

Dr. Tsao, Associate Professor of Medicine, Icahn School of Medicine at Mt Sinai, Medical Director, Ruttenberg Treatment Center, Mt. Sinai ...

video

Che-Kai Tsao, MD, discusses the current application of biomarkers in renal cell carcinoma

Dr. Tsao, Associate Professor of Medicine, Icahn School of Medicine at Mt Sinai, Medical Director, Ruttenberg Treatment Center, Mt. Sinai ...

video

Saad Usmani, MD, FACP, considers data in smoldering MM coming out of ASCO 2019

Dr. Usmani, Chief, Plasma Cell Disorders Program, Director, Clinical Research in Hematologic Malignancies, Levine Cancer Institute/Atrium Health, Clinical Professor of ...

video

Parameswaran Hari, MD, speculates on whether KRD will replace stem cell transplant

Dr. Hari, Professor of Hematology, Medical College of Wisconsin, speculates on whether KRD will replace stem cell transplant

video

Tomasz M. Beer MD, FACP, outlines results from Keynote-365 presented at ASCO 2019

Dr. Beer, Deputy Director, Knight Cancer Institute, Chief Medical Officer, Center for Early Detection Advanced Research, Oregon Health & Science ...

video

Shirish Madhav Gadgeel, MBBS, on treating patients who have already received PD-L1 targeting agents

Dr. Gadgeel, Mary Lou Kennedy Research Professor, Thoracic Oncology, Professor, Department of Internal Medicine, Division of Hematology/Oncology, Co-Leader, Thoracic Oncology ...

video

Che-Kai Tsao, MD, on deciding between I-O + TKIs combinations indicated for the treatment of RCC

Dr. Tsao, Associate Professor of Medicine, Icahn School of Medicine at Mt Sinai, Medical Director, Ruttenberg Treatment Center, Mt. Sinai ...

Related Videos

video-image

Saad Usmani, MD, FACP, considers data in smoldering MM coming out of ASCO 2019

video-image

Che-Kai Tsao, MD, discusses the current application of biomarkers in renal cell carcinoma

video-image

Che-Kai Tsao, MD, offers opinion on the results of the ENZAMET study in mHSPC

video-image

Sandip Patel, MD, speculates on the impact of the RELAY trial presented at ASCO 2019

video-image

Sandip Patel, MD, on treatment in the 2nd line setting following PD-L1 targeting agents

video-image

Che-Kai Tsao, MD, elaborates on results from the TITAN study in mCRPC from ASCO '19

video-image

Michael B. Atkins, MD, regarding the long-term follow up of Checkmate-004 in metastatic melanoma

video-image

Parameswaran Hari, MD, speculates on whether KRD will replace stem cell transplant

video-image

Tomasz M. Beer MD, FACP, considers the role of metformin in castrate-resistant prostate cancer

video-image

Josep Tabernero, MD, PhD, speculates on exciting clinical trial outcomes in gastric cancer

video-image

Shirish Madhav Gadgeel, MBBS, offers opinion on the results of the RELAY trial from ASCO 2019

video-image

Parameswaran Hari, MD, discusses the role of CAR-T therapy in multiple myeloma

video-image

Lowell L. Hart, MD, FACP, explains the mechanism of action for trilaciclib

video-image

Sandip Patel, MD, describes the ideal patient to receive Alimta + Keytruda based on Keynote-189

video-image

Philip Philip MD, PhD, FRCP, on the APACT trial in surgically resected pancreatic adenocarcinoma

video-image

Che-Kai Tsao, MD, on deciding between I-O + TKIs combinations indicated for the treatment of RCC

video-image

Shirish Madhav Gadgeel, MBBS, on treating patients who have already received PD-L1 targeting agents

video-image

Tomasz M. Beer MD, FACP, outlines results from Keynote-365 presented at ASCO 2019

video-image

Tomasz M. Beer MD, FACP, on the efficacy of abiraterone + enzalutamide in mCRPC

video-image

Michael B. Atkins, MD, on the role of IMDC classification in treatment decision-making